ClinicalTrials.gov
ClinicalTrials.gov Menu

German Spondyloarthritis Inception Cohort (GESPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01277419
Recruitment Status : Recruiting
First Posted : January 17, 2011
Last Update Posted : March 14, 2017
Sponsor:
Collaborators:
German Federal Ministry of Education and Research (BMBF): 2000-2007 and 2010-current
2010-current: AbbVie (Abbott)
Amgen
Centocor, Inc.
Schering-Plough
Wyeth is now a wholly owned subsidiary of Pfizer
2015-current: Berlin Institute of Health (BIH)
Information provided by (Responsible Party):
Denis Poddubnyy, Charite University, Berlin, Germany

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : July 2020
Publications of Results:

Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):